Provided by Tiger Trade Technology Pte. Ltd.

NRX Pharmaceuticals Inc.

3.45
-0.1100-3.09%
Post-market: 3.510.0600+1.74%19:44 EDT
Volume:898.03K
Turnover:3.15M
Market Cap:149.37M
PE:-4.45
High:3.61
Open:3.52
Low:3.44
Close:3.56
52wk High:5.06
52wk Low:1.62
Shares:43.30M
Float Shares:36.46M
Volume Ratio:1.04
T/O Rate:2.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7754
EPS(LYR):-1.3374
ROE:-682.61%
ROA:-63.99%
PB:-878.65
PE(LYR):-2.58

Loading ...

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 17

NRx Pharmaceuticals confirms path to NDA following Type C meeting

TIPRANKS
·
Mar 16

FDA agrees to review NRX-100 NDA using clinical trials and real-world evidence

Reuters
·
Mar 16

NRX Pharmaceuticals Inc - to Submit Nda for NRX-100 by June 2026

THOMSON REUTERS
·
Mar 16

NRX Pharmaceuticals (Nasdaq:Nrxp) Confirms Path to New Drug Application With Real World Data and Broader Proposed Indication for NRX-100 (Ketamine) Following Type C FDA Meeting

THOMSON REUTERS
·
Mar 16

NRX Pharmaceuticals Inc: No Additional Clinical Trials Were Requested

THOMSON REUTERS
·
Mar 16

NRX Pharmaceuticals Inc - FDA Confirms No Additional Nonclinical Data or Bridging Studies Required for NRX-100

THOMSON REUTERS
·
Mar 16

NRX Pharmaceuticals Inc expected to post breakeven results a share - Earnings Preview

Reuters
·
Mar 13

NRX Pharmaceuticals Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Mar 10

Hope Therapeutics, an NRX Subsidiary (Nasdaq:Nrxp) Announces Opening of Palm Beach, Fl Clinic Offering One Day Treatment for Depression and Ptsd

THOMSON REUTERS
·
Mar 09

HOPE Therapeutics, an NRx Subsidiary (Nasdaq:NRXP) Announces opening of Palm Beach, FL Clinic offering One Day treatment for Depression and PTSD

GlobeNewswire
·
Mar 09

NRX Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 04

NRx Pharmaceuticals price target raised to $45 from $40 at H.C. Wainwright

TIPRANKS
·
Mar 03

NRx Pharmaceuticals Names Prof. Joshua Brown Chief Medical Innovation Officer

Reuters
·
Mar 02

NRX Pharmaceuticals (Nasdaq: Nrxp) Appoints Prof. Joshua Brown Md, Phd, as Chief Medical Innovation Officer

THOMSON REUTERS
·
Mar 02